{"id":"rhgh-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Arthralgia"},{"rate":null,"effect":"Carpal tunnel syndrome"},{"rate":null,"effect":"Fluid retention"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"rhGH is a recombinant form of endogenous human growth hormone that activates growth hormone receptors on target tissues, promoting linear growth in children, increasing lean body mass, reducing fat mass, and enhancing metabolic function. It stimulates insulin-like growth factor 1 (IGF-1) production, which mediates many of its anabolic and growth-promoting effects.","oneSentence":"Recombinant human growth hormone (rhGH) binds to growth hormone receptors to stimulate growth, metabolism, and protein synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:53.329Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth hormone deficiency in children"},{"name":"Growth hormone deficiency in adults"},{"name":"Short stature due to growth hormone insufficiency"}]},"trialDetails":[{"nctId":"NCT07037420","phase":"PHASE2","title":"ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly","status":"RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2025-10-28","conditions":"Acromegaly","enrollment":60},{"nctId":"NCT07481734","phase":"PHASE2","title":"Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis","enrollment":120},{"nctId":"NCT07481656","phase":"PHASE4","title":"Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)","status":"NOT_YET_RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2026-04-10","conditions":"Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury","enrollment":160},{"nctId":"NCT07036003","phase":"PHASE1, PHASE2","title":"Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)","status":"RECRUITING","sponsor":"Dr. David Wasserstein","startDate":"2025-10-31","conditions":"Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)","enrollment":34},{"nctId":"NCT06382155","phase":"PHASE2","title":"A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-10-21","conditions":"Idiopathic Short Stature","enrollment":100},{"nctId":"NCT06927310","phase":"PHASE3","title":"The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature","status":"RECRUITING","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2025-04-28","conditions":"Idiopathic Short Stature","enrollment":300},{"nctId":"NCT07221851","phase":"PHASE3","title":"Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders","status":"RECRUITING","sponsor":"Ascendis Pharma A/S","startDate":"2025-12-12","conditions":"Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature","enrollment":186},{"nctId":"NCT07450001","phase":"PHASE1, PHASE2","title":"A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-03-06","conditions":"Pediatric Growth Hormone Deficiency","enrollment":128},{"nctId":"NCT07450053","phase":"PHASE1, PHASE2","title":"A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-03-06","conditions":"Idiopathic Short Stature","enrollment":128},{"nctId":"NCT05681299","phase":"PHASE4","title":"Effects of GH and Lirglutide on AgRP","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-05-01","conditions":"Healthy, Growth Hormone Deficiency","enrollment":40},{"nctId":"NCT07309562","phase":"PHASE3","title":"The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age","status":"RECRUITING","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2026-01-20","conditions":"Small for Gestational Age","enrollment":141},{"nctId":"NCT06930625","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs","status":"RECRUITING","sponsor":"Debiopharm International SA","startDate":"2025-11-26","conditions":"Acromegaly","enrollment":119},{"nctId":"NCT06668805","phase":"PHASE2","title":"A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-11-22","conditions":"Short Stature Homeobox- Containing Gene SHOX Deficiency, Noonan Syndrome, Turner Syndrome","enrollment":54},{"nctId":"NCT07226089","phase":"PHASE3","title":"Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2026-02","conditions":"ISS, SGA","enrollment":254},{"nctId":"NCT07260500","phase":"PHASE2","title":"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-11-11","conditions":"Short Stature Children Born Small for Gestational Age (SGA)","enrollment":72},{"nctId":"NCT06803589","phase":"EARLY_PHASE1","title":"Growth Hormone for the Treatment of Gastroparesis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-10-22","conditions":"Gastroparesis","enrollment":10},{"nctId":"NCT05775523","phase":"","title":"A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin","status":"RECRUITING","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2023-03-20","conditions":"Growth Hormone Deficiency","enrollment":500},{"nctId":"NCT05509894","phase":"","title":"Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-06-20","conditions":"Pediatric Growth Hormone Deficiency","enrollment":565},{"nctId":"NCT05690386","phase":"PHASE2","title":"A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2023-02-15","conditions":"Turner Syndrome","enrollment":48},{"nctId":"NCT05171855","phase":"PHASE3","title":"A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2021-12-16","conditions":"Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency","enrollment":220},{"nctId":"NCT07323329","phase":"PHASE2, PHASE3","title":"Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-10-10","conditions":"Infertility, Infertility (IVF Patients)","enrollment":165},{"nctId":"NCT07264595","phase":"PHASE1, PHASE2","title":"A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-12","conditions":"Pediatric Growth Hormone Deficiency","enrollment":88},{"nctId":"NCT07259564","phase":"PHASE2","title":"A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-12-19","conditions":"Adult Growth Hormone Deficiency (AGHD)","enrollment":120},{"nctId":"NCT03375788","phase":"PHASE2","title":"Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-01-17","conditions":"Non-Alcoholic Fatty Liver Disease, Obesity, Obesity, Abdominal","enrollment":51},{"nctId":"NCT04020913","phase":"","title":"Skeletal Muscle Effects of GH in Boys","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2019-07-22","conditions":"Growth Hormone Deficiency, Idiopathic Short Stature","enrollment":45},{"nctId":"NCT05602766","phase":"","title":"Ngenla Subcutaneous Injection Special Investigation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-02-06","conditions":"Growth Hormone Deficiency Without Epiphyseal Closure","enrollment":1},{"nctId":"NCT05746650","phase":"NA","title":"Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury","status":"RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2023-02-24","conditions":"Muscle Injury","enrollment":40},{"nctId":"NCT06037473","phase":"","title":"The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg","status":"RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2023-08-01","conditions":"Growth Hormone Treatment, Growth Disorders","enrollment":2600},{"nctId":"NCT07126288","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Kexing Pharmaceutical Co., Ltd.","startDate":"2025-08-31","conditions":"Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone","enrollment":268},{"nctId":"NCT03255694","phase":"PHASE2","title":"A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2017-05-12","conditions":"Dwarfism","enrollment":360},{"nctId":"NCT05355272","phase":"PHASE2","title":"Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-03-11","conditions":"Gulf War Syndrome, Adult Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT06797505","phase":"PHASE1","title":"A Bioequivalence Study of Two Different PEG-rhGH Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-02-10","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT06554717","phase":"PHASE2","title":"Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-07-07","conditions":"HIV-1-infection, Frailty, Impaired Physical Function","enrollment":100},{"nctId":"NCT02968004","phase":"PHASE3","title":"Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2016-12","conditions":"Pediatric Growth Hormone Deficiency","enrollment":224},{"nctId":"NCT07016802","phase":"PHASE1","title":"A Clinical Study of GenSci134 in Healthy Male Adults","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-06-23","conditions":"Healthy Volunteers","enrollment":64},{"nctId":"NCT02375620","phase":"PHASE2","title":"Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2015-04-23","conditions":"Short Stature Children Born Small for Gestational Age (SGA)","enrollment":96},{"nctId":"NCT02500316","phase":"PHASE2","title":"Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2014-02","conditions":"Growth Hormone Deficiency (GHD)","enrollment":48},{"nctId":"NCT06135168","phase":"PHASE1","title":"A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-10-31","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":60},{"nctId":"NCT06135155","phase":"PHASE1","title":"A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-11-06","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":48},{"nctId":"NCT06385145","phase":"PHASE1","title":"A Bioavailability Study of Two Different PEG-rhGH Preparations.","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-05-08","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":16},{"nctId":"NCT06907121","phase":"PHASE2, PHASE3","title":"Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health","status":"NOT_YET_RECRUITING","sponsor":"Integrant Pty Ltd","startDate":"2025-06-01","conditions":"Arthritis Ankle, Arthritis Knee","enrollment":60},{"nctId":"NCT06863363","phase":"PHASE4","title":"PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"","conditions":"Non-diabetic Obesity","enrollment":212},{"nctId":"NCT03554265","phase":"PHASE3","title":"Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2018-08-06","conditions":"Traumatic Brain Injury, Fatigue, Cognitive Impairment","enrollment":72},{"nctId":"NCT06840691","phase":"PHASE1","title":"A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-05","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT04615273","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2020-12-03","conditions":"Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency","enrollment":264},{"nctId":"NCT06722079","phase":"","title":"A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2022-11-08","conditions":"Turner Syndrome","enrollment":743},{"nctId":"NCT06331026","phase":"PHASE1","title":"A Bioequivalence Study of Two Different PEG-rhGH Preparations.","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-04-09","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT06110910","phase":"","title":"Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)","status":"RECRUITING","sponsor":"Xiaoping Luo","startDate":"2023-03-01","conditions":"Childhood Short Stature","enrollment":10000},{"nctId":"NCT06354023","phase":"PHASE2","title":"Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis","status":"SUSPENDED","sponsor":"John Sledge","startDate":"2025-02-08","conditions":"Osteoarthritis, Knee","enrollment":23},{"nctId":"NCT04522180","phase":"PHASE2","title":"A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2021-01-04","conditions":"Acromegaly","enrollment":34},{"nctId":"NCT06448195","phase":"PHASE4","title":"Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-01-01","conditions":"Growth Hormone Treatment","enrollment":40},{"nctId":"NCT03344458","phase":"PHASE3","title":"A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial","status":"COMPLETED","sponsor":"Ascendis Pharma A/S","startDate":"2017-12-19","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":298},{"nctId":"NCT04003207","phase":"PHASE2","title":"Growth Hormone Treatment in Children With Phelan McDermid Syndrome","status":"COMPLETED","sponsor":"Swathi Sethuram","startDate":"2019-09-13","conditions":"Phelan McDermid Syndrome","enrollment":6},{"nctId":"NCT04633057","phase":"PHASE3","title":"A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2021-01-25","conditions":"Pediatric Growth Hormone Deficiency","enrollment":168},{"nctId":"NCT06113952","phase":"","title":"A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2024-01","conditions":"Pediatric Growth Hormone Deficiency","enrollment":""},{"nctId":"NCT04513171","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2018-12-26","conditions":"Growth Hormone Deficiency","enrollment":434},{"nctId":"NCT05838885","phase":"PHASE2","title":"A Trial of YPEG-rhGH in Children With Short Stature","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2022-02-15","conditions":"Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome","enrollment":78},{"nctId":"NCT05809947","phase":"NA","title":"Mechanisms of Tissue Repair After Muscle Injury and Tendon Strain","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2023-04-11","conditions":"Muscle; Injury, Quadriceps (Thigh), Tendon Strain","enrollment":25},{"nctId":"NCT02934399","phase":"","title":"Dynamic Hormone Diagnostics in Endocrine Disease","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2016-10","conditions":"Adrenal Insufficiency, Congenital Adrenal Hyperplasia, Cushing Syndrome","enrollment":528},{"nctId":"NCT00742157","phase":"PHASE4","title":"Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2003-09-01","conditions":"Short Bowel Syndrome","enrollment":5},{"nctId":"NCT03223025","phase":"PHASE3","title":"Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Cinnagen","startDate":"2016-03-09","conditions":"Idiopathic Growth Hormone Deficiency","enrollment":30},{"nctId":"NCT05900661","phase":"PHASE2, PHASE3","title":"The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"Poor Responders","enrollment":300},{"nctId":"NCT00571727","phase":"PHASE2, PHASE3","title":"Long-Term Treatment With rhIGF-1 in GHIS","status":"COMPLETED","sponsor":"Ipsen","startDate":"1991-05-20","conditions":"Growth Hormone Insensitivity Syndrome","enrollment":92},{"nctId":"NCT04998500","phase":"NA","title":"Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2021-08-01","conditions":"Fibrosis","enrollment":10},{"nctId":"NCT03123913","phase":"PHASE1","title":"Study of Testosterone and rHGH in FSHD","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2017-12-18","conditions":"Facioscapulohumeral Muscular Dystrophy","enrollment":20},{"nctId":"NCT05602090","phase":"PHASE2, PHASE3","title":"Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2022-02-01","conditions":"Poor Ovarian Reserve","enrollment":120},{"nctId":"NCT05144035","phase":"PHASE4","title":"A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2022-04-06","conditions":"Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder","enrollment":138},{"nctId":"NCT00572156","phase":"PHASE2","title":"rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency","status":"TERMINATED","sponsor":"Ipsen","startDate":"2007-12","conditions":"Insulin-like Growth Factor-1 Deficiency","enrollment":106},{"nctId":"NCT03967249","phase":"PHASE2","title":"Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2019-07-25","conditions":"Acromegaly","enrollment":39},{"nctId":"NCT05353192","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2022-09-23","conditions":"Achondroplasia","enrollment":38},{"nctId":"NCT04484051","phase":"","title":"Growth Hormone Study in Adults With Prader-Willi Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2023-03-24","conditions":"Prader-Willi Syndrome","enrollment":25},{"nctId":"NCT03038594","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-11-01","conditions":"Burns, Growth Hormone Treatment","enrollment":13},{"nctId":"NCT04121780","phase":"PHASE2","title":"Growth Hormone Replacement Therapy for Retried Professional Football Players","status":"RECRUITING","sponsor":"Center for Neurological Studies","startDate":"2019-10-08","conditions":"TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury","enrollment":42},{"nctId":"NCT02339090","phase":"PHASE3","title":"Long-Acting Growth Hormone in Children Compared to Daily rhGH","status":"COMPLETED","sponsor":"Versartis Inc.","startDate":"2015-08-26","conditions":"Growth Disorders","enrollment":138},{"nctId":"NCT05660356","phase":"EARLY_PHASE1","title":"Growth Hormone Deficiency in Mild Traumatic Brain Injury","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2023-02","conditions":"Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild","enrollment":20},{"nctId":"NCT02217345","phase":"PHASE2","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-06-02","conditions":"Nonalcoholic Fatty Liver Disease (NAFLD)","enrollment":131},{"nctId":"NCT03548415","phase":"PHASE2","title":"Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2018-09-13","conditions":"Acromegaly","enrollment":43},{"nctId":"NCT02726542","phase":"EARLY_PHASE1","title":"Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-05-03","conditions":"NAFLD","enrollment":24},{"nctId":"NCT05281341","phase":"PHASE4","title":"Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-01-13","conditions":"Female Infertility","enrollment":160},{"nctId":"NCT02597660","phase":"PHASE2","title":"A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy","status":"WITHDRAWN","sponsor":"Hospital for Special Surgery, New York","startDate":"2020-05-01","conditions":"Tendinopathy","enrollment":""},{"nctId":"NCT01715324","phase":"PHASE4","title":"Adjuvant Growth Therapy in in Vitro Fertilization","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2014-06-25","conditions":"Infertility","enrollment":288},{"nctId":"NCT03305016","phase":"PHASE3","title":"A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2017-11-13","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":146},{"nctId":"NCT02781727","phase":"PHASE3","title":"A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2016-12-13","conditions":"Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases","enrollment":162},{"nctId":"NCT02410356","phase":"PHASE3","title":"Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-04-30","conditions":"Growth Hormone Deficiency","enrollment":34},{"nctId":"NCT02195947","phase":"PHASE4","title":"Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":141},{"nctId":"NCT01169103","phase":"PHASE2","title":"Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-03","conditions":"Obesity","enrollment":22},{"nctId":"NCT03831880","phase":"PHASE3","title":"Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD","status":"COMPLETED","sponsor":"Pfizer","startDate":"2019-02-07","conditions":"Growth Hormone Deficiency","enrollment":87},{"nctId":"NCT01861717","phase":"PHASE4","title":"A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.","status":"TERMINATED","sponsor":"Saint John's Cancer Institute","startDate":"2013-05","conditions":"Acromegaly","enrollment":4},{"nctId":"NCT03874013","phase":"PHASE3","title":"Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2017-12-07","conditions":"Growth Hormone Deficiency","enrollment":44},{"nctId":"NCT01626833","phase":"PHASE2, PHASE3","title":"Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-03","conditions":"Anorexia Nervosa, Interruption of Growth, Delayed Puberty","enrollment":15},{"nctId":"NCT03616509","phase":"PHASE4","title":"GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2017-06-19","conditions":"Prader-Willi Syndrome","enrollment":30},{"nctId":"NCT00488124","phase":"PHASE2","title":"Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2005-11","conditions":"Idiopathic Short Stature","enrollment":120},{"nctId":"NCT03075644","phase":"PHASE3","title":"A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2017-03-03","conditions":"Growth Hormone Disorder, Adult Growth Hormone Deficiency","enrollment":62},{"nctId":"NCT00447499","phase":"PHASE3","title":"Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel","status":"COMPLETED","sponsor":"Ipsen","startDate":"2007-04","conditions":"Acromegaly","enrollment":59},{"nctId":"NCT00747604","phase":"","title":"IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex","status":"TERMINATED","sponsor":"Ipsen","startDate":"2006-06","conditions":"Primary Insulin-like Growth Factor-1 Deficiency","enrollment":1378},{"nctId":"NCT04588844","phase":"NA","title":"Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2020-12-01","conditions":"Poor Ovarian Reserve","enrollment":200},{"nctId":"NCT04532554","phase":"PHASE4","title":"Growth Hormone in Obese Cases With Covid-19","status":"WITHDRAWN","sponsor":"ClinAmygate","startDate":"2020-10-26","conditions":"Covid19","enrollment":""},{"nctId":"NCT00283595","phase":"PHASE2","title":"Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2006-01","conditions":"Anorexia Nervosa, Osteopenia, Osteoporosis","enrollment":21},{"nctId":"NCT04420481","phase":"PHASE3","title":"Growth Hormone in Ischemic Heart Failure","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2004-04-28","conditions":"Heart Failure, Systolic, Ischemic Heart Disease Chronic","enrollment":37},{"nctId":"NCT03309891","phase":"PHASE2","title":"Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Genexine, Inc.","startDate":"2016-01-18","conditions":"Growth Hormone Deficiency","enrollment":56}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["rhGH","daily growth hormone","recombinant growth hormone therapy"],"phase":"marketed","status":"active","brandName":"rhGH injection","genericName":"rhGH injection","companyName":"Changchun GeneScience Pharmaceutical Co., Ltd.","companyId":"changchun-genescience-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant human growth hormone (rhGH) binds to growth hormone receptors to stimulate growth, metabolism, and protein synthesis. Used for Growth hormone deficiency in children, Growth hormone deficiency in adults, Short stature due to growth hormone insufficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}